Skip Ribbon Commands
Skip to main content
Navigate Up
EnglishFrancais
Current Year Centre for Addiction
and Mental Health

Brain protein may explain depression in pre-menopause phase

June 4, 2014 (Toronto) – Women nearing menopause have higher levels of a brain protein linked to depression than both younger and menopausal women, a new study by the Centre for Addiction and Mental Health (CAMH) shows.

This finding may explain the high rates of first-time depression seen among women in this transitional stage of life, known as perimenopause.

Dr. Jeff MeyerDr. Jeffrey Meyer, Senior Scientist at CAMH’s Campbell Family Mental Health Research Institute.

“This is the first time that a biological change in the brain has been identified in perimenopause which is also associated with clinical depression,” says Senior Scientist Dr. Jeffrey Meyer of CAMH’s Campbell Family Mental Health Research Institute. Specifically, Dr. Meyer’s research team found elevated levels of the chemical monoamine oxidase-A (MAO-A) among women aged 41-51.

The study was published today in JAMA Psychiatry.

During perimenopause, a common symptom is mood changes such as crying. Rates of first-time clinical depression among this group reach 16 to 17 per cent, and a similar number get milder depressive symptoms.

MAO-A is an enzyme that is a pro-oxidant and breaks down brain chemicals such as serotonin, norepinephrine and dopamine, which help to maintain normal mood. Dr. Meyer has previously linked high levels of MAO-A to major depressive disorder, depressed mood related to alcohol dependence and smoking cessation, and the period immediately after childbirth.

To investigate if MAO-Alevels may explain the mood changes during perimenopause, his research team conducted brain scans of three groups of women using a brain imaging technique called positron emission tomography (PET) in CAMH’s Research Imaging Centre. Among the three groups of women, 19 were of reproductive age, 27 were in perimenopause, and 12 were in menopause.

On average, levels of MAO-A were 34 per cent higher in women with perimenopause than in the younger women, and 16 per cent higher than those in menopause.

The women in perimenopause also reported a higher tendency to cry, based on a questionnaire called the Adult Crying Inventory, and this was associated with high MAO-A levels in the front part of the brain, the prefrontal cortex. The researchers had also predicted that MAO-A levels would drop during menopause, once fluctuating levels of estrogen stabilized, and this also proved to be the case.

The results suggest new opportunities for prevention, says Dr. Meyer, who holds a Canada Research Chair in the Neurochemistry of Major Depression. 

“Using PET imaging, we can test treatments to see if they can prevent this elevation of MAO-A, and potentially prevent clinical depression,” he says. One approach may be a dietary supplement, which he is currently investigating in another study of women after childbirth, to prevent post-partum depression.Another approach may be to offer hormone replacement therapy (HRT) at an earlier stage to prevent the fluctuation of estrogen levels, which is also linked to higher amounts of MAO-A.

First author of the study was post-doctoral fellow Dr. Vivien Rekkas. This research was supported by the Canadian Institutes of Health Research, the Brain and Behavior Research Foundation, the Canada Foundation for Innovation and the Ministry of Research and Innovation.

- 30 -

The Centre for Addiction and Mental Health (CAMH) is Canada's largest mental health and addiction teaching hospital, as well as one of the world's leading research centres in its field. CAMH combines clinical care, research, education, policy development and health promotion to help transform the lives of people affected by mental health and addiction issues. CAMH is fully affiliated with the University of Toronto, and is a Pan American Health Organization/World Health Organization Collaborating Centre. For more information, please visit www.camh.ca.

Media Contact:

Kate Richards
Media Relations
Centre for Addiction and Mental Health (CAMH)
416 535 8501 x36015
media@camh.ca

CAMH Switchboard 416-535-8501
CAMH General Information Toronto: 416-595-6111 Toll Free: 1-800-463-6273
Connex Ontario Help Lines
Queen St.
1001 Queen St. W
Toronto, ON
M6J 1H4
Russell St.
33 Russell St.
Toronto, ON
M5S 2S1
College St.
250 College St.
Toronto, ON
M5T 1R8
Nine offices across Ontario